SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-20-000654
Filing Date
2020-10-29
Accepted
2020-10-29 11:21:55
Documents
1
Effectiveness Date
2020-10-29

Document Format Files

Seq Description Document Type Size
1 8A_Cert_IKT.pdf CERT 217984
  Complete submission text file 0001354457-20-000654.txt   301283
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-39676 | Film No.: 201271268
SIC: 2836 Biological Products, (No Diagnostic Substances)